These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6420737)

  • 1. Improvement of cervical factor by high-dose estrogen and human menopausal gonadotropin therapy with ultrasound monitoring.
    Check JH; Adelson HG
    Obstet Gynecol; 1984 Feb; 63(2):179-81. PubMed ID: 6420737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of cervical factor with ethinyl estradiol and human menopausal gonadotropins.
    Check JH; Wu CH; Dietterich C; Lauer CC; Liss J
    Int J Fertil; 1986; 31(2):148-52. PubMed ID: 2875037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of the cervical factor. I. Improvement with a short-course treatment of high-dose estrogen.
    Check JH; Chase JS; Adelson HG; Dietterich C
    Int J Fertil; 1986; 31(5):360-1. PubMed ID: 2898438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of the cervical factor. II. Employment of pelvic sonography in diagnosis.
    Check JH; Chase JS; Wu CH; Goldberg BB; Adelson HG; Rankin A
    Int J Fertil; 1986; 31(5):362-4. PubMed ID: 2898439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new protocol for individualized hMG therapy by estrogen priming and cervical mucus monitoring.
    Igarashi M; Yazaki C; Yamada K; Taniguchi Y
    Int J Fertil; 1983; 28(2):78-84. PubMed ID: 6136480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic regimens and monitoring techniques for human menopausal gonadotropin administration.
    March CM
    J Reprod Med; 1978 Sep; 21(3 Suppl):198-204. PubMed ID: 722708
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the cervical factor in ovulation induction].
    Murillo A; Carranza-Lira S; Matienzo F; Montero J; Rodríguez ML; Murrieta S; Merino G; Morán C
    Ginecol Obstet Mex; 1995 Mar; 63():115-8. PubMed ID: 7744291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum estradiols versus pelvic sonography in monitoring HMG therapy.
    Check JH; Goldberg BB; Kurtz A; Adelson HG; Dietterich C
    Int J Fertil; 1985; 30(2):61-3. PubMed ID: 2865227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of human menopausal gonadotropins as therapy for abnormal cervical mucus.
    Soto-Albors C; Daly DC; Ying YK
    Fertil Steril; 1989 Jan; 51(1):58-62. PubMed ID: 2535987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen in the treatment of abnormal cervical mucus infertility.
    Punnonen R; Multamäki S; Honkonen E
    Acta Eur Fertil; 1984; 15(3):171-4. PubMed ID: 6485707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal requirements for a successful outcome in anovulatory patients treated with human menopausal gonadotropins.
    Sallam HN; Sallam AN; Ezzeldin FE; Agamia AF; Abou-Ali AH
    Int J Fertil Womens Med; 2000; 45(4):285-91. PubMed ID: 10997485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of HMG-HCG administration on the vaginal epithelium, cervical mucus, endometrium and ovary.
    Silló-Seidl G
    Acta Eur Fertil; 1973 Sep; 4(3):109-12. PubMed ID: 4788936
    [No Abstract]   [Full Text] [Related]  

  • 13. Are estrogen assays essential for monitoring gonadotropin stimulant therapy?
    Hardiman P; Thomas M; Osgood V; Vlassopoulou V; Ginsburg J
    Gynecol Endocrinol; 1990 Dec; 4(4):261-9. PubMed ID: 2127985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further data on the usefulness of combined high-dose estrogen and human menopausal gonadotropins for cervical factor.
    Balasch J; Vanrell JA
    Int J Fertil; 1986; 31(4):263, 267, 271. PubMed ID: 2878895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate cervical mucus--a cause of "idiopathic" infertility.
    Sher G; Katz M
    Fertil Steril; 1976 Aug; 27(8):886-91. PubMed ID: 955130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation-inducing drugs versus specific mucus therapy for cervical factor.
    Check JH; Dietterich C; Lauer C; Liss J
    Int J Fertil; 1991; 36(2):108-12. PubMed ID: 1674931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vivo technique for screening immunologic factors in the etiology of the unexplained poor postcoital test.
    Check JH; Nowroozi K; Adelson HG; Bollendorf A; Chern R; Press M
    Int J Fertil; 1990; 35(4):215-21. PubMed ID: 1977713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful pregnancy, achieved by ovulation induction using a human menopausal gonadotropin low-dose step-up protocol in an infertile patient with Kallmann's syndrome.
    Nakagawa K; Iwasaki W; Sato M; Ito M; Kawachiya S; Murashima A; Kitagawa M; Natori M; Saito H
    J Obstet Gynaecol Res; 2005 Apr; 31(2):140-3. PubMed ID: 15771640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does ovulation stimulation improve fertility in women with minimal/mild endometriosis after laser laparoscopy?
    Kemmann E; Ghazi D; Corsan G; Bohrer MK
    Int J Fertil Menopausal Stud; 1993; 38(1):16-21. PubMed ID: 8485606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of clinical and laboratory methods in monitoring human menopausal gonadotropin therapy.
    Marrs RP; March CM; Mishell DR
    Fertil Steril; 1980 Dec; 34(6):542-7. PubMed ID: 6778716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.